Evidence map›Paper›PMID 25246621›Full record

Trial reportPediatrics2014

Pertussis immunization in infancy and adolescent asthma medication.

Hartmut Vogt, Lennart Bråbäck, Anna-Maria Kling, Maria Grünewald, Lennart Nilsson

Registry-linked trialOpen access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06286007 (Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06286007 unknown statusnot on this mapstarted 2023, after this paper: background citation

Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control

Typeobservational_patient_registrySponsorHospital Clinico Universitario de SantiagoRan2023 to 2026Enrolled784ConditionsAsthma, Pertussis, RSV InfectionArmsPCR
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Eosinophils and Bacteria, the Beginning of a Story.International journal of molecular sciences · 2021
    Review
  5. Article
  6. [False beliefs about vaccines].Atencion primaria · 2019
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hartmut VogtDepartment of Paediatrics and Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden hartmut.vogt@liu.se.
Lennart BråbäckDepartment of Research and Development, Sundsvall Hospital, Sundsvall, Sweden; Occupational and Environmental Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden;
Anna-Maria KlingUnit for Statistics and Surveillance, Department of Monitoring and Evaluation, and.
Maria GrünewaldUnit for Vaccine and Register, Department of Monitoring and Evaluation, Public Health Agency of Sweden, Stockholm, Solna, Sweden; and.
Lennart NilssonAllergy Centre, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, County Council of Östergötland, Linköping, Sweden.
Linköping University · SEPublic Health Agency of Sweden · SESundsvall Municipality · SE

Funding

PERTUSSIS CLINICAL TRIAL (PART 2)N01AI015125 · NIAID · NATIONAL BACTERIOLOGICAL LABORATORY · PI OLIN, PATRICK · 1991 to 1999
–
NIAID NIH HHS N01 AI015125
6 · The paper itself

Abstract

BACKGROUND AND

objectivesChildhood immunization may influence the development of asthma, possibly due to lack of infections or a shift in the T-helper cell type 1/T-helper cell type 2/regulatory T cells balance. We therefore investigated whether pertussis immunization in infancy is associated with asthma medication in adolescence.

methodsAfter 14 years of no general pertussis vaccination, almost 82,000 Swedish children were immunized for pertussis in a vaccination trial between June 1, 1993, and June 30, 1994. In a follow-up analysis of almost 80,000 children, their data were compared with those of ∼100,000 nonvaccinated children, born during a 5-month period before and a 7-month period after the vaccination trial. Data for the main outcome variable (ie, dispensed prescribed asthma medication for each individual in the cohort during 2008-2010) were obtained from the national prescription database. Multivariate regression models were used to calculate the effect size of vaccination on dispensed asthma medication (odds ratios [OR], 95% confidence intervals [CI]). Approaches similar to intention-to-treat and per-protocol methods were used.

resultsThe prevalence rates of various asthma medications for study patients at 15 years of age differed between 4.6% and 7.0%. The crude ORs for any asthma medication and antiinflammatory treatment in pertussis-vaccinated children after intention-to-treat analysis were 0.97 (95% CI: 0.93-1.00) and 0.94 (95% CI: 0.90-0.98), respectively. Corresponding adjusted ORs were 0.99 (95% CI: 0.95-1.03) and 0.97 (95% CI: 0.92-1.01). Similar ORs were found after per-protocol analysis.

conclusionsPertussis immunization in infancy does not increase the risk of asthma medication use in adolescents. Our study presents evidence that pertussis immunization in early childhood can be considered safe with respect to long-term development of asthma.

Indexed as

Immunization ScheduleAdolescentAnti-Asthmatic AgentsAsthmaCohort StudiesDiphtheria-Tetanus-Pertussis VaccineFemaleFollow-Up StudiesHumansInfantMaleRegistriesSwedenWhooping CoughAnti-Asthmatic AgentsDiphtheria-Tetanus-Pertussis Vaccineasthmaimmunizationmedicationnational cohortpertussis

Identifiers

PMID25246621
PMCPMC4179099
OpenAlexW2094215730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.